# L3MBTL1

## Overview
L3MBTL1 is a gene that encodes the L3MBTL histone methyl-lysine binding protein 1, a member of the polycomb group of proteins, which plays a crucial role in chromatin remodeling and transcriptional repression. The protein is characterized by its three malignant brain tumor (MBT) repeats, which enable it to bind specifically to mono- and dimethylated lysine residues on histones, thereby influencing chromatin compaction and gene expression (Li2007Structural; Trojer2008Beyond). L3MBTL1 is involved in maintaining genomic stability by interacting with components of the DNA replication machinery and regulating erythroid differentiation in hematopoietic progenitor cells (Gurvich2010L3MBTL1; Perna2010Depletion). Clinically, the gene is implicated in various hematologic malignancies, particularly those associated with deletions on chromosome 20q, and is considered a tumor suppressor due to its role in preventing genomic instability (Gurvich2010L3MBTL1; Perna2010Depletion).

## Structure
The L3MBTL1 protein is characterized by its three malignant brain tumor (MBT) repeats, which are crucial for its function as a histone methyl-lysine binding protein. These MBT domains are structurally related to chromatin-binding domains such as chromo-, tudor-, and PWWP-domains, and they play a significant role in recognizing mono- and di-methylated lysine residues on histones (Trojer2008Beyond). The protein's structure includes a triangular architecture formed by the three MBT modules, each containing a distinct binding pocket. Pocket 2 is particularly important for binding mono- and dimethylated lysines, featuring a narrow and deep cavity lined with aromatic residues that facilitate hydrogen bonding (Li2007Structural).

The second MBT domain is responsible for binding methylated lysines on histones such as H4K20me1 and H1bK26me1/2, contributing to chromatin compaction and transcriptional repression (Trojer2008Beyond). L3MBTL1 also contains a Zn-finger and a sterile alpha motif (SAM), which mediate dimerization and may aid in chromatin compaction (Trojer2008Beyond). The protein's ability to bind methylated lysines is influenced by the structural configuration of its aromatic cage motifs, which are essential for its function as a methyllysine reader (Li2007Structural).

## Function
L3MBTL1 is a polycomb protein that functions as a transcriptional repressor in healthy human cells. It plays a critical role in maintaining genome stability by interacting with components of the DNA replication machinery, such as Cdc45, MCM2-7, and PCNA, which are essential for normal replication fork progression. Depletion of L3MBTL1 leads to replicative stress, DNA breaks, and activation of the DNA damage response (DDR), contributing to genomic instability (Gurvich2010L3MBTL1).

L3MBTL1 binds preferentially to mono- and dimethylated lysines on histones, particularly H4K20me1, through its MBT domains. This binding is crucial for its function in transcriptional repression and chromatin compaction, influencing gene expression and cell cycle regulation (Kalakonda2008Histone). The protein's interaction with the H4K20 monomethyltransferase PR-SET7 is essential for its repressive activity, as it helps maintain the monomethylation state of H4K20, preventing its conversion to dimethylation, which is associated with DDR activation (Kalakonda2008Histone).

L3MBTL1 also regulates erythroid differentiation in hematopoietic progenitor cells by restraining premature differentiation into the erythroid lineage. Knockdown of L3MBTL1 results in increased erythroid differentiation and altered intracellular signaling pathways (Perna2010Depletion).

## Clinical Significance
The L3MBTL1 gene is implicated in several hematologic malignancies, particularly those associated with deletions on chromosome 20q. In myeloid disorders such as myeloproliferative neoplasms (MPNs), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML), the deletion of the 20q region, which includes L3MBTL1, is a common chromosomal abnormality. This deletion is observed in approximately 10% of MPNs, 4% of MDS cases, and 1-2% of AML cases (Gurvich2010L3MBTL1; Perna2010Depletion). The loss of L3MBTL1 is associated with increased erythroid differentiation and sensitivity to erythropoietin, suggesting its role in the pathogenesis of polycythemia vera, a type of MPN (Perna2010Depletion).

In Shwachman-Diamond syndrome (SDS), a rare genetic disorder, the deletion of the paternal allele of L3MBTL1, which is imprinted and expressed only from the paternal side, may contribute to hematological abnormalities (Nacci2016Parental). The gene's role as a tumor suppressor is further supported by its involvement in maintaining genomic stability. Loss of L3MBTL1 leads to replicative stress, DNA damage, and genomic instability, which are critical factors in the development of myeloid malignancies (Gurvich2010L3MBTL1).

## Interactions
L3MBTL1 is known to interact with various proteins and chromatin structures, playing a significant role in transcriptional repression and chromatin compaction. It binds to mono- and dimethylated lysine residues on histones, particularly H4K20me1/2, and interacts with core histones and linker histone H1 (Gurvich2010L3MBTL1; Trojer2008Beyond). L3MBTL1 forms complexes with heterochromatin protein 1 gamma (HP1γ) and the retinoblastoma protein (pRB), which are involved in repressing E2F target genes (Mao2018ActivityInduced; Trojer2008Beyond). It also interacts with the transcription factor TEL, influencing E2F target gene expression (Trojer2008Beyond).

L3MBTL1 is involved in DNA replication and repair, interacting with components of the DNA replication machinery, including the MCM2-7 complex, Cdc45, and PCNA. These interactions are crucial for normal replication fork progression and maintaining genomic stability (Gurvich2010L3MBTL1). The protein's interaction with PR-Set7, a histone methyltransferase, suggests a role in the methylation of H4K20, which is important for DNA replication and damage response pathways (Gurvich2010L3MBTL1). These interactions highlight L3MBTL1's multifaceted role in chromatin regulation and genome stability.


## References


[1. (Trojer2008Beyond) Patrick Trojer and Danny Reinberg. Beyond histone methyl-lysine binding: how malignant brain tumor (mbt) protein l3mbtl1 impacts chromatin structure. Cell Cycle, 7(5):578–585, March 2008. URL: http://dx.doi.org/10.4161/cc.7.5.5544, doi:10.4161/cc.7.5.5544. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/cc.7.5.5544)

[2. (Li2007Structural) Haitao Li, Wolfgang Fischle, Wooikoon Wang, Elizabeth M. Duncan, Lena Liang, Satoko Murakami-Ishibe, C. David Allis, and Dinshaw J. Patel. Structural basis for lower lysine methylation state-specific readout by mbt repeats of l3mbtl1 and an engineered phd finger. Molecular Cell, 28(4):677–691, November 2007. URL: http://dx.doi.org/10.1016/J.MOLCEL.2007.10.023, doi:10.1016/j.molcel.2007.10.023. This article has 238 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/J.MOLCEL.2007.10.023)

[3. (Mao2018ActivityInduced) Wenjie Mao, Anna C. Salzberg, Motokazu Uchigashima, Yuto Hasegawa, Hanno Hock, Masahiko Watanabe, Schahram Akbarian, Yuka Imamura Kawasawa, and Kensuke Futai. Activity-induced regulation of synaptic strength through the chromatin reader l3mbtl1. Cell Reports, 23(11):3209–3222, June 2018. URL: http://dx.doi.org/10.1016/j.celrep.2018.05.028, doi:10.1016/j.celrep.2018.05.028. This article has 28 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2018.05.028)

[4. (Gurvich2010L3MBTL1) Nadia Gurvich, Fabiana Perna, Andrea Farina, Francesca Voza, Silvia Menendez, Jerard Hurwitz, and Stephen D. Nimer. L3mbtl1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability. Proceedings of the National Academy of Sciences, 107(52):22552–22557, December 2010. URL: http://dx.doi.org/10.1073/pnas.1017092108, doi:10.1073/pnas.1017092108. This article has 70 citations.](https://doi.org/10.1073/pnas.1017092108)

[5. (Kalakonda2008Histone) N Kalakonda, W Fischle, P Boccuni, N Gurvich, R Hoya-Arias, X Zhao, Y Miyata, D MacGrogan, J Zhang, J K Sims, J C Rice, and S D Nimer. Histone h4 lysine 20 monomethylation promotes transcriptional repression by l3mbtl1. Oncogene, 27(31):4293–4304, April 2008. URL: http://dx.doi.org/10.1038/onc.2008.67, doi:10.1038/onc.2008.67. This article has 122 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2008.67)

[6. (Perna2010Depletion) Fabiana Perna, Nadia Gurvich, Ruben Hoya-Arias, Omar Abdel-Wahab, Ross L. Levine, Takashi Asai, Francesca Voza, Silvia Menendez, Lan Wang, Fan Liu, Xinyang Zhao, and Stephen D. Nimer. Depletion of l3mbtl1 promotes the erythroid differentiation of human hematopoietic progenitor cells: possible role in 20q− polycythemia vera. Blood, 116(15):2812–2821, October 2010. URL: http://dx.doi.org/10.1182/blood-2010-02-270611, doi:10.1182/blood-2010-02-270611. This article has 45 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2010-02-270611)

[7. (Nacci2016Parental) Lucia Nacci, Roberto Valli, Rita Maria Pinto, Marco Zecca, Marco Cipolli, Jacopo Morini, Simone Cesaro, Emanuela Boveri, Vittorio Rosti, Paola Corti, Maura Ambroni, Francesco Pasquali, Cesare Danesino, Emanuela Maserati, and Antonella Minelli. Parental origin of the deletion del(20q) in shwachman‐diamond patients and loss of the paternally derived allele of the imprinted l3mbtl1 gene. Genes, Chromosomes and Cancer, 56(1):51–58, September 2016. URL: http://dx.doi.org/10.1002/gcc.22401, doi:10.1002/gcc.22401. This article has 12 citations.](https://doi.org/10.1002/gcc.22401)